Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review.
Saved in:
| Title: | Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review. |
|---|---|
| Authors: | Becerril-Rico, Jared1,2 (AUTHOR), Delgado-Montes, Yerenia A.3 (AUTHOR), Ortiz-Sánchez, Elizabeth1 (AUTHOR) elinfkb@yahoo.com.mx |
| Source: | Leukemia & Lymphoma. Nov2023, Vol. 64 Issue 11, p1822-1831. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2023.2243357 |
